查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1541182

2024-2032 年按產品服務、循環生物標記（循環腫瘤細胞、無細胞 DNA、細胞外囊泡等）、最終用戶和地區分類的乳癌液體活體組織切片市場報告

Breast Cancer Liquid Biopsy Market Report by Product Services, Circulating Biomarker (Circulating Tumor Cells, Cell-Free DNA, Extracellular Vesicles, and Others), End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球乳癌液體切片市場規模達到1.304億美元。

乳癌液體切片是指利用血液作為樣本來鑑定腫瘤標記的非侵入性醫療程序。它有助於評估乳癌疾病的進展並檢測表皮生長因子受體 (EGFR) 基因突變，幫助臨床醫生在正確的時間選擇最佳的治療方案。此過程中使用的一些常見生物標記包括循環腫瘤細胞(CTC)、細胞外囊泡、循環腫瘤DNA 等。點識別用於癌症治療等

乳癌液體切片市場趨勢：

乳癌盛行率的不斷上升以及對非侵入性醫療程序的需求不斷增加主要推動了全球乳癌液體活體組織切片市場。除此之外，消費者對液體活體組織切片技術的眾多好處的認知不斷提高，包括更快的結果、更低的成本、最小的健康風險、非侵入性等，也促進了市場的成長。此外，各全球組織正在進行提高意識活動，以教育個人有關乳房健康和癌症診斷措施的知識。這與越來越多的政府和私人對乳癌活體組織切片和其他相關醫療程序的報銷政策相結合，正在為市場創造積極的前景。除此之外，許多製造商正在大力投資引進先進的活體組織切片技術，以增強乳癌管理的多個方面，例如預後預測、復發的早期診斷、連續採樣、疾病進展的有效縱向監測和此外，個人化治療的新興趨勢，加上聚合酶鏈反應（PCR）和下一代定序（NGS）在癌症檢測中的廣泛採用，將繼續推動全球乳癌液體活體組織切片市場的發展。

本報告回答的關鍵問題

  • 2023年全球乳癌液體切片市場規模有多大？ 2024-2032年全球乳癌液體切片市場的預期成長率是多少？
  • COVID-19 對全球乳癌液體切片市場有何影響？
  • 推動全球乳癌液體切片市場的關鍵因素是什麼？
  • 從產品服務來看，全球乳癌液體切片市場的詳細情形如何？
  • 全球乳癌液體切片市場的關鍵區域有哪些？
  • 全球乳癌液體切片市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球乳癌液體切片市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品服務

  • 試劑盒
    • 市場趨勢
    • 市場預測
  • 儀器儀表
    • 市場趨勢
    • 市場預測
  • 服務
    • 市場趨勢
    • 市場預測

第 7 章：市場細分：依流通生物標記

  • 循環腫瘤細胞 (CTC)
    • 市場趨勢
    • 市場預測
  • 遊離 DNA (cfDNA)
    • 市場趨勢
    • 市場預測
  • 細胞外囊泡 (EV)
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 參考實驗室
    • 市場趨勢
    • 市場預測
  • 醫院和醫師實驗室
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Biocept Inc.
    • Bio-Rad Laboratories Inc.
    • F. Hoffmann-La Roche AG
    • Fluxion Biosciences Inc.
    • Guardant Health Inc.
    • Illumina Inc.
    • Menarini Silicon Biosystems (The Menarini Group)
    • NeoGenomics Laboratories Inc.
    • Qiagen
    • Sysmex Europe SE (Sysmex Corporation)
Product Code: SR112024A6047

The global breast cancer liquid biopsy market size reached US$ 130.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 497.2 Million by 2032, exhibiting a growth rate (CAGR) of 15.5% during 2024-2032.

Breast cancer liquid biopsy refers to a non-invasive medical procedure that utilizes blood as a sample for the identification of tumor markers. It assists in evaluating the progression of breast cancer disease and detects Epidermal Growth Factor Receptor (EGFR) gene mutations that help clinicians in choosing the best course of action at the right time. Some of the common biomarkers that are used in this process include circulating tumor cells (CTC), extracellular vesicles, circulating tumor DNA, etc. Breast cancer liquid biopsy offers several benefits, including minimal invasiveness, characterization of new lesions, drug and therapeutic target identifications for cancer treatment, etc.

Breast Cancer Liquid Biopsy Market Trends:

The growing prevalence of breast cancer along with the escalating demand for non-invasive medical procedures is primarily driving the global breast cancer liquid biopsy market. In addition to this, the rising consumer awareness towards numerous benefits associated with the liquid biopsy technique, including quicker results, lower cost, minimal health risk, non-invasiveness, etc., is also augmenting the market growth. Moreover, various global organizations are conducting awareness campaigns to educate individuals about breast health and cancer diagnostic measures. This, in confluence with the increasing number of government and private reimbursement policies for breast cancer biopsy and other related medical procedures, is creating a positive outlook for the market. Apart from this, numerous manufacturers are making significant investments in the introduction of advanced biopsy techniques that enables the enhancement of several aspects of breast cancer management, such as prediction of prognosis, early diagnosis of relapse, serial sampling, efficient longitudinal monitoring of disease progress and response to treatment, etc. Furthermore, the emerging trend of personalized therapeutics coupled with the widespread adoption of polymerase chain reaction (PCR) and next-generation sequencing (NGS) for cancer detection will continue to drive the global breast cancer liquid biopsy market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global breast cancer liquid biopsy market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product services, circulating biomarker and end user.

Breakup by Product Services:

Reagent Kits

Instruments

Services

Breakup by Circulating Biomarker:

Circulating Tumor Cells (CTCs)

Cell-Free DNA (cfDNA)

Extracellular Vesicles (EVs)

Others

Breakup by End User:

Reference Laboratories

Hospitals and Physician Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Biocept Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Fluxion Biosciences Inc., Guardant Health Inc., Illumina Inc., Menarini Silicon Biosystems (The Menarini Group), NeoGenomics Laboratories Inc., Qiagen and Sysmex Europe SE (Sysmex Corporation).

Key Questions Answered in This Report

  • 1. What was the size of the global breast cancer liquid biopsy market in 2023?
  • 2. What is the expected growth rate of the global breast cancer liquid biopsy market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global breast cancer liquid biopsy market?
  • 4. What are the key factors driving the global breast cancer liquid biopsy market?
  • 5. What is the breakup of the global breast cancer liquid biopsy market based on the product services?
  • 6. What are the key regions in the global breast cancer liquid biopsy market?
  • 7. Who are the key players/companies in the global breast cancer liquid biopsy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Breast Cancer Liquid Biopsy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Services

  • 6.1 Reagent Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Circulating Biomarker

  • 7.1 Circulating Tumor Cells (CTCs)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cell-Free DNA (cfDNA)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Extracellular Vesicles (EVs)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Reference Laboratories
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospitals and Physician Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Biocept Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bio-Rad Laboratories Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 F. Hoffmann-La Roche AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Fluxion Biosciences Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Guardant Health Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Illumina Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Menarini Silicon Biosystems (The Menarini Group)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 NeoGenomics Laboratories Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Qiagen
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Sysmex Europe SE (Sysmex Corporation)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Breast Cancer Liquid Biopsy Market: Major Drivers and Challenges
  • Figure 2: Global: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Breast Cancer Liquid Biopsy Market: Breakup by Product Services (in %), 2023
  • Figure 5: Global: Breast Cancer Liquid Biopsy Market: Breakup by Circulating Biomarker (in %), 2023
  • Figure 6: Global: Breast Cancer Liquid Biopsy Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Breast Cancer Liquid Biopsy Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Breast Cancer Liquid Biopsy (Reagent Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Breast Cancer Liquid Biopsy (Reagent Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Breast Cancer Liquid Biopsy (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Breast Cancer Liquid Biopsy (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Breast Cancer Liquid Biopsy (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Breast Cancer Liquid Biopsy (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Breast Cancer Liquid Biopsy (Circulating Tumor Cells (CTCs)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Breast Cancer Liquid Biopsy (Circulating Tumor Cells (CTCs)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Breast Cancer Liquid Biopsy (Cell-Free DNA (cfDNA)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Breast Cancer Liquid Biopsy (Cell-Free DNA (cfDNA)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Breast Cancer Liquid Biopsy (Extracellular Vesicles (EVs)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Breast Cancer Liquid Biopsy (Extracellular Vesicles (EVs)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Breast Cancer Liquid Biopsy (Other Circulating Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Breast Cancer Liquid Biopsy (Other Circulating Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Breast Cancer Liquid Biopsy (Reference Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Breast Cancer Liquid Biopsy (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Breast Cancer Liquid Biopsy (Hospitals and Physician Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Breast Cancer Liquid Biopsy (Hospitals and Physician Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Breast Cancer Liquid Biopsy (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Breast Cancer Liquid Biopsy (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Breast Cancer Liquid Biopsy Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Breast Cancer Liquid Biopsy Industry: SWOT Analysis
  • Figure 78: Global: Breast Cancer Liquid Biopsy Industry: Value Chain Analysis
  • Figure 79: Global: Breast Cancer Liquid Biopsy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Breast Cancer Liquid Biopsy Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Breast Cancer Liquid Biopsy Market Forecast: Breakup by Product Services (in Million US$), 2024-2032
  • Table 3: Global: Breast Cancer Liquid Biopsy Market Forecast: Breakup by Circulating Biomarker (in Million US$), 2024-2032
  • Table 4: Global: Breast Cancer Liquid Biopsy Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Breast Cancer Liquid Biopsy Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Breast Cancer Liquid Biopsy Market: Competitive Structure
  • Table 7: Global: Breast Cancer Liquid Biopsy Market: Key Players